We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Enters $1.5 Billion Deal for Inflammation Drugs
GSK Enters $1.5 Billion Deal for Inflammation Drugs
August 25, 2006
GlaxoSmithKline (GSK) and ChemoCentryx have announced a partnership to develop and market new medicines to treat a variety of inflammatory disorders.